Seeking Alpha

Foundation Medicine soars in debut, Evoke underwhelms

  • Foundation Medicine (FMI +79%) — which markets molecular information-enabled products to physicians and biopharma firms — opens at $31.50, well above its expected range of $14-16. Through June 30, the company had logged sales of $11.1M and incurred an operating loss of $17.1M.
  • Evoke Pharma (EVOK -5.8%) — which develops treatments for GI diseases — opens at $11.15, below its expected range of $12-14.
From other sites
Comments (1)
  • Mking30
    , contributor
    Comments (140) | Send Message
     
    How and Why?
    25 Sep 2013, 01:31 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector